Evidence map›Paper›PMID 35149246›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid, and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture.

Michalina A Montaño, Meagan J Bemer, Kate B Heller, Allison Meisner, Zarna Marfatia, Elena A Rechkina, Leah R Padgett, Charlotte L Ahls, Douglas Rains, Linhui Hao and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Guideline
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Michalina A MontañoDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA. Electronic address: micham@uw.edu.
Meagan J BemerDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA.
Kate B HellerDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA.
Allison MeisnerDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Zarna MarfatiaDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA.
Elena A RechkinaDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA.
Leah R PadgettQuantigen Biosciences, Fishers, IN.
Charlotte L AhlsQuantigen Biosciences, Fishers, IN.
Douglas RainsQuantigen Biosciences, Fishers, IN.
Linhui HaoDepartment of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA.
Tien-Ying HsiangDepartment of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA.
Gerard A CangelosiDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, WA.
Alexander L GreningerDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Jason L CanteraPATH, Seattle, WA.
Allison GoldenPATH, Seattle, WA.
Roger B PeckPATH, Seattle, WA.
David S BoylePATH, Seattle, WA.
Michael GaleDepartment of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA.
Paul K DrainDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA.
University of Washington · USProgram for Appropriate Technology in Health · USInfectious Disease Research Institute · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
Host inflammatory response to SARS-CoV-2R21AI158788 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2021 to 2022
$485k
NIAID NIH HHS R21 AI158788NIAID NIH HHS U01 AI151698NIH HHS P51 OD010425
6 · The paper itself

Abstract

objectivesThis study assesses and compares the performance of different swab types and specimen collection sites for SARS-CoV-2 testing, to reference standard real-time reverse transcriptase-polymerase chain reaction (RT-PCR) and viral culture.

methodsSymptomatic adults with COVID-19 who visited routine COVID-19 testing sites used spun polyester and FLOQSwabs to self-collect specimens from the anterior nares and tongue. We evaluated the self-collected specimen from anterior nares and tongue swabs for the nucleocapsid (N) or spike (S) antigen of SARS-CoV-2 by RT-PCR and then compared these results with results from RT-PCR and viral cultures from nurse-collected nasopharyngeal swabs.

resultsDiagnostic sensitivity was highest for RT-PCR testing conducted using specimens from the anterior nares collected on FLOQSwabs (84%; 95% CI 68-94%) and spun polyester swabs (82%; 95% CI 66-92%), compared to RT-PCR tests conducted using specimens from nasopharyngeal swabs. Relative to viral culture from nasopharyngeal swabs, diagnostic sensitivities were higher for RT-PCR and antigen testing of anterior nares swabs (91-100%) than that of tongue swabs (18-81%). Antigen testing of anterior nares swabs had higher sensitivities against viral culture (91%) than against nasopharyngeal RT-PCR (38-70%). All investigational tests had high specificity compared with nasopharyngeal RT-PCR. Spun polyester swabs are equally effective as FLOQSwabs for anterior nasal RT-PCR testing.

conclusionsWe found that anterior nares specimens were more sensitive than tongue swab specimens or antigen testing for detecting SARS-CoV-2 by RT-PCR. Thus, self-collected anterior nares specimens may represent an alternative method for diagnostic SARS-CoV-2 testing in some settings.

Indexed as

COVID-19Nucleic AcidsAdultCOVID-19 TestingHumansNasopharynxNucleocapsidPolymerase Chain ReactionSARS-CoV-2Sensitivity and SpecificitySpecimen HandlingTongueNucleic Acidsantigen detectionCOVID-19diagnostic performanceSARS-CoV-2

Identifiers

PMID35149246
PMCPMC8827388
OpenAlexW4211055328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.